The present stock price for Aldeyra Therapeutics Inc (ALDX) is $5.3. In the last trading session, the stock made a considerable jump, reaching $11.0 after an opening price of $5.25. The stock briefly fell to $6.0 before ending the session at $5.44.
In terms of market performance, Aldeyra Therapeutics Inc had a fairly even. The highest value for the stock in the past year was $7.20 on 03/12/25, and the lowest value was recorded at $1.14 on 04/03/25.
52-week price history of ALDX Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Aldeyra Therapeutics Inc’s current trading price is -26.46% away from its 52-week high, while its distance from the 52-week low is 364.47%. The stock’s price range during this period has spanned from $1.14 to $7.20. In the Healthcare sector, the Aldeyra Therapeutics Inc’s shares surpassed a trading volume of approximately 0.84 million for the day, which was noticeably lower compared to the average daily volume of 9.1.13 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Aldeyra Therapeutics Inc (ALDX) has experienced a quarterly rise of 99.81% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 317.15M and boasts a workforce of 9 employees.
A Closer Look at Analysts’ Ratings for Aldeyra Therapeutics Inc
As of right now, 4 analysts are rating Aldeyra Therapeutics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.78, with a change in price of -0.86. Similarly, Aldeyra Therapeutics Inc recorded 1,539,185 in trading volume during the last 100 days, posting a change of -14.11%.
Examining ALDX’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ALDX stands at 0.24. Similarly, the long-term debt-to-equity ratio is also 0.24.
ALDX Stock Stochastic Average
Today’s raw stochastic average for Aldeyra Therapeutics Inc over the last 50 days is 87.73%.This indicates a increase from the raw stochastic average of the past 20 days, which was 77.26%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 87.31% and 89.92%, respectively.
ALDX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price gain of 32.04% this year. Over the last six months, there has been a weaker performance of 5.27%. The price of ALDX fallen by 50.85% during the last 30 days period. For the last 5-days stocks have slided -1.76%.
